Swiss Pharma CEO Warns of Trump's Generic Drug Tariff Threat
The CEO of Swiss pharmaceutical company Sandoz, Richard Saynor, has warned that President Donald Trump's threatened tariffs on imported generic drugs could lead to price increases or reduced supply for American patients. Saynor stated, 'Patients pay the tariff,' indicating that consumers would ultimately bear the cost of such tariffs.8 sourcesSee all sources







